Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial

BACKGROUND: Three 52-week studies in COPD have assessed the efficacy and safety of single-inhaler extrafine formulation triple therapy combining beclomethasone dipropionate (BDP), formoterol fumarate (FF) and glycopyrronium (G) delivered via pressurized metered-dose inhaler (pMDI). BDP/FF/G is now b...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeh, Kai-Michael, Kuna, Piotr, Corradi, Massimo, Viaud, Isabelle, Guasconi, Alessandro, Georges, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814657/
https://www.ncbi.nlm.nih.gov/pubmed/33488071
http://dx.doi.org/10.2147/COPD.S291030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814657/
https://www.ncbi.nlm.nih.gov/pubmed/33488071
http://dx.doi.org/10.2147/COPD.S291030

Ejemplares similares